Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's disease

被引:49
|
作者
Tremblay-Mercier, Jennifer [1 ]
Madjar, Cecile [1 ,2 ]
Das, Samir [2 ]
Binette, Alexa Pichet [1 ,3 ]
Dyke, Stephanie O. M. [2 ,3 ,4 ]
Etienne, Pierre [1 ,3 ]
Lafaille-Magnan, Marie-Elyse [1 ,3 ,5 ]
Remz, Jordana [1 ]
Bellec, Pierre [6 ,7 ]
Collins, D. Louis [3 ,4 ]
Rajah, M. Natasha [1 ,3 ]
Bohbot, Veronique [1 ,3 ]
Leoutsakos, Jeannie-Marie [8 ]
Iturria-Medina, Yasser [2 ,3 ,4 ]
Kat, Justin [1 ,2 ]
Hoge, Richard D. [2 ,3 ,4 ,7 ]
Gauthier, Serge [1 ,3 ,9 ]
Tardif, Christine L. [3 ,4 ]
Chakravarty, M. Mallar [1 ,3 ]
Poline, Jean-Baptiste [2 ,3 ,4 ]
Rosa-Neto, Pedro [1 ,3 ,4 ,9 ]
Evans, Alan C. [1 ,2 ,3 ,4 ]
Villeneuve, Sylvia [1 ,2 ,3 ,4 ]
Poirier, Judes [1 ,3 ]
Breitner, John C. S. [1 ,3 ]
机构
[1] Douglas Mental Hlth Inst Res Ctr, StoP AD Ctr, Montreal, PQ, Canada
[2] McGill Univ, McGill Ctr Integrat Neurosci, Montreal Neurol Inst, Montreal, PQ, Canada
[3] McGill Univ, Montreal, PQ, Canada
[4] McGill Univ, McConnell Brain Imaging Ctr, Montreal Neurol Inst, Montreal, PQ, Canada
[5] Jewish Gen Hosp Montreal, Ctr Child Dev & Mental Hlth, Montreal, PQ, Canada
[6] CRIUGM Univ Montreal, Montreal, PQ, Canada
[7] Univ Montreal, Montreal, PQ, Canada
[8] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[9] McGill Univ, Res Ctr Studies Aging, Montreal, PQ, Canada
关键词
Pre-symptomatic Alzheimer Disease; Biomarkers; Observational cohort; Open Science; Neuroimaging; Cerebrospinal Fluid proteins; AGE-OF-ONSET; IDENTIFICATION TEST; COGNITIVE DECLINE; DEMENTIA; RISK; ASSOCIATION; GENOTYPE; HISTORY;
D O I
10.1016/j.nicl.2021.102733
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
To move Alzheimer Disease (AD) research forward it is essential to collect data from large cohorts, but also make such data available to the global research community. We describe the creation of an open science dataset from the PREVENT-AD (PResymptomatic EValuation of Experimental or Novel Treatments for AD) cohort, composed of cognitively unimpaired older individuals with a parental or multiple-sibling history of AD. From 2011 to 2017, 386 participants were enrolled (mean age 63 years old +/- 5) for sustained investigation among whom 349 have retrospectively agreed to share their data openly. Repositories are findable through the unified interface of the Canadian Open Neuroscience Platform and contain up to five years of longitudinal imaging data, cerebral fluid biochemistry, neurosensory capacities, cognitive, genetic, and medical information. Imaging data can be accessed openly at https://openpreventad.loris.ca while most of the other information, sensitive by nature, is accessible by qualified researchers at https://registeredpreventad.loris.ca. In addition to being a living resource for continued data acquisition, PREVENT-AD offers opportunities to facilitate understanding of AD pathogenesis.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Mapping the progression of vascular CSF biomarkers in pre-symptomatic "at-risk" healthy subjects in the PREVENT-AD program
    Labonte, A.
    Dea, J.
    Theroux, L.
    Tremblay-Mercier, J.
    Rosa-Neto, P.
    Etienne, P.
    Breitner, J.
    Poirier, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 676 - 676
  • [2] Detecting Alzheimer's disease at the pre-symptomatic stages
    Small, GW
    AGEING BRAIN: THE NEUROBIOLOGY AND NEUROPSYCHIATRY OF AGEING, 2003, : 259 - 273
  • [3] Attitudes, Motivations, and Barriers to Pre-Symptomatic Alzheimer's Disease Screening: Development and Validation of the 'Perceptions regarding pRE-symptomatic Alzheimer's Disease Screening' (PRE-ADS) Questionnaire
    Makri, Marina
    Gkioka, Mara
    Moraitou, Despina
    Fidani, Liana
    Tegos, Thomas
    Tsolaki, Magdalini
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 95 (03) : 1163 - 1174
  • [4] Osteopontin: A novel marker of pre-symptomatic sporadic Alzheimer's disease
    Quesnel, Marc James
    Labonte, Anne
    Picard, Cynthia
    Bowie, Daniel C.
    Zetterberg, Henrik
    Blennow, Kaj
    Brinkmalm, Ann
    Villeneuve, Sylvia
    Poirier, Judes
    ALZHEIMERS & DEMENTIA, 2024, 20 (09) : 6008 - 6031
  • [5] National Institute on Aging Research on Pre-symptomatic/Pre-clinical Alzheimer's Disease
    Buckholtz, Neil
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S19 - S19
  • [6] Attitudes of Family Members and Caregivers Regarding Alzheimer's Disease Pre-Symptomatic Screening
    Makri, Marina
    Despoti, Akyllina
    Teichmann, Birgit
    Gkioka, Mara
    Moraitou, Despina
    Fidani, Liana
    Tegos, Thomas
    Tsolaki, Magdalini
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2024, 8 (01) : 723 - 735
  • [7] Improved predictive model for pre-symptomatic mild cognitive impairment and Alzheimer's disease
    Smith, C. D.
    Chebrolu, H.
    Markesbery, W. R.
    Liu, J.
    NEUROLOGICAL RESEARCH, 2008, 30 (10) : 1091 - 1096
  • [8] Generalization of memory-related brain function in asymptomatic older women with a family history of late onset Alzheimer's Disease: Results from the PREVENT-AD Cohort
    Rabipour, Sheida
    Rajagopal, Sricharana
    Pasvanis, Stamatoula
    Rajah, M. Natasha
    NEUROBIOLOGY OF AGING, 2021, 104 : 42 - 56
  • [9] Validation of the "Perceptions Regarding pRE-Symptomatic Alzheimer's Disease Screening" (PRE-ADS) Questionnaire in the German Population: Attitudes, Motivations, and Barriers to Pre-Symptomatic Dementia Screening
    Angelidou, Ioanna Antigoni
    Stocker, Hannah
    Beyreuther, Konrad
    Teichmann, Birgit
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 97 (01) : 309 - 325
  • [10] Tracking change on MRI in a case of familial Alzheimer's disease: 11 years of imaging spanning pre-symptomatic to Alzheimer's disease
    Anderson, VM
    Godbolt, AK
    Price, SL
    Janssen, JC
    Rossor, MN
    NEUROBIOLOGY OF AGING, 2004, 25 : S267 - S268